Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
18 Years
N/A
Both
Unsuspected Pulmonary Embolism
Trial Information
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Inclusion Criteria:
- cancer patients with a first diagnosis of unsuspected PE
Exclusion Criteria:
1. age <18 years;
2. ongoing anticoagulant therapy for previous VTE or indications for long-term
anticoagulation other than deep vein thrombosis (DVT) or PE;
3. life expectancy less than 3 months.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Recurrent (symptomatic) vein thromboembolism, including pulmonary embolism and deep vein thrombosis
Outcome Description:
Suspected recurrent PE with one of the following: new intra-luminal filling defect on CT scan, MRI scan, or pulmonary angiogram; new perfusion defect of at least 75% on V/Q lung scan; inconclusive spiral CT, pulmonary angiography or lung scan with demonstration of DVT in the lower extremities by CUS or venography Fatal PE is: PE based on objective diagnostic testing or autopsy or death not attributed to a documented cause and for which DVT/PE cannot be ruled out. Suspected (recurrent) DVT with one of the following findings: abnormal CUS; an intra-luminal filling defect on venography.
Outcome Time Frame:
one year
Safety Issue:
No
Authority:
Italy: Ethics Committee
Study ID:
215/2012
NCT ID:
NCT01727427
Start Date:
November 2012
Completion Date:
November 2016
Related Keywords:
- Unsuspected Pulmonary Embolism
- Unsuspected
- pulmonary embolism
- cancer
- Embolism
- Pulmonary Embolism
Name | Location |
|---|
